Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 87 articles:
HTML format
Text format



Single Articles


    March 2017
  1. OTTO CM
    Heartbeat: Diabetes and heart failure.
    Heart. 2017;103:327-328.
    PubMed     Text format    


  2. OTTO CM
    Heartbeat:Blood urea nitrogen to creatinine ratio predicts outcome in acute heart failure.
    Heart. 2017;103:399-401.
    PubMed     Text format    


    January 2017
  3. BARRA S, Providencia R, Duehmke R, Boveda S, et al
    Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure.
    Heart. 2017 Jan 19. pii: heartjnl-2016-310677. doi: 10.1136/heartjnl-2016-310677
    PubMed     Text format     Abstract available


    December 2016
  4. SCHRANZ D, Akintuerk H, Voelkel NF
    'End-stage' heart failure therapy: potential lessons from congenital heart disease: from pulmonary artery banding and interatrial communication to parallel circulation.
    Heart. 2016 Dec 23. pii: heartjnl-2015-309110. doi: 10.1136/heartjnl-2015-309110
    PubMed     Text format     Abstract available


  5. KINUGASA Y, Yamamoto K
    The challenge of frailty and sarcopenia in heart failure with preserved ejection fraction.
    Heart. 2016 Dec 9. pii: heartjnl-2016-309995. doi: 10.1136/heartjnl-2016-309995.
    PubMed     Text format     Abstract available


  6. OTTO CM
    Heartbeat: Heart failure and obstructive lung disease: are beta-blockers underused?
    Heart. 2016;102:1855-1856.
    PubMed     Text format    


    November 2016
  7. INGLIS SC, Clark RA, Dierckx R, Prieto-Merino D, et al
    Structured telephone support or non-invasive telemonitoring for patients with heart failure.
    Heart. 2016 Nov 18. pii: heartjnl-2015-309191. doi: 10.1136/heartjnl-2015-309191
    PubMed     Text format    


    October 2016
  8. TAJIK AA, Dickstein K
    What constitutes optimal neurohumoral antagonism in chronic heart failure?
    Heart. 2016 Oct 14. pii: heartjnl-2015-308039. doi: 10.1136/heartjnl-2015-308039
    PubMed     Text format    


  9. NUNEZ J
    Blood urea nitrogen to creatinine ratio in acute heart failure: an old concept brought to reality?
    Heart. 2016 Oct 14. pii: heartjnl-2016-310536. doi: 10.1136/heartjnl-2016-310536
    PubMed     Text format    


    September 2016
  10. RAHIMI K
    The long and unfinished journey of hyperglycaemia and heart failure research.
    Heart. 2016 Sep 29. pii: heartjnl-2016-310336. doi: 10.1136/heartjnl-2016-310336
    PubMed     Text format    


  11. NAIR A, Sajeev CG, Muneer K
    A case of recent myocardial infarction with cardiac failure.
    Heart. 2016 Sep 29. pii: heartjnl-2016-309715. doi: 10.1136/heartjnl-2016-309715
    PubMed     Text format     Abstract available


  12. MATSUE Y, van der Meer P, Damman K, Metra M, et al
    Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure.
    Heart. 2016 Sep 22. pii: heartjnl-2016-310112. doi: 10.1136/heartjnl-2016-310112
    PubMed     Text format     Abstract available


  13. NASR E, Ibrahim M, Yacoub M
    Heart failure in a neonate with multiple cardiac masses.
    Heart. 2016 Sep 21. pii: heartjnl-2016-310251. doi: 10.1136/heartjnl-2016-310251
    PubMed     Text format     Abstract available


  14. OU SM, Chen HT, Kuo SC, Chen TJ, et al
    Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309687. doi: 10.1136/heartjnl-2016-309687
    PubMed     Text format     Abstract available


  15. SKRTIC S, Cabrera C, Olsson M, Schnecke V, et al
    Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309806. doi: 10.1136/heartjnl-2016-309806
    PubMed     Text format     Abstract available


  16. KIM CH, Al-Kindi SG, Jandali B, Askari AD, et al
    Incidence and risk of heart failure in systemic lupus erythematosus.
    Heart. 2016 Sep 9. pii: heartjnl-2016-309561. doi: 10.1136/heartjnl-2016-309561.
    PubMed     Text format     Abstract available


    August 2016
  17. EMDIN CA, Conrad N, Kiran A, Salimi-Khorshidi G, et al
    Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales.
    Heart. 2016 Aug 16. pii: heartjnl-2016-309706. doi: 10.1136/heartjnl-2016-309706
    PubMed     Text format     Abstract available


  18. OSENI AO, Qureshi WT, Almahmoud MF, Bertoni AG, et al
    Left ventricular hypertrophy by ECG versus cardiac MRI as a predictor for heart failure.
    Heart. 2016 Aug 2. pii: heartjnl-2016-309516. doi: 10.1136/heartjnl-2016-309516.
    PubMed     Text format     Abstract available


    July 2016
  19. MEALING S, Woods B, Hawkins N, Cowie MR, et al
    Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure.
    Heart. 2016 Jul 13. pii: heartjnl-2015-308883. doi: 10.1136/heartjnl-2015-308883
    PubMed     Text format     Abstract available


  20. GIJSBERTS CM, Benson L, Dahlstrom U, Sim D, et al
    Ethnic differences in the association of QRS duration with ejection fraction and outcome in heart failure.
    Heart. 2016 Jul 11. pii: heartjnl-2015-309212. doi: 10.1136/heartjnl-2015-309212
    PubMed     Text format     Abstract available


  21. BURDEN A
    QRS duration and ethnicity: implications for heart failure therapy.
    Heart. 2016 Jul 11. pii: heartjnl-2016-309760. doi: 10.1136/heartjnl-2016-309760
    PubMed     Text format    


  22. LIPWORTH B, Skinner D, Devereux G, Thomas V, et al
    Underuse of beta-blockers in heart failure and chronic obstructive pulmonary disease.
    Heart. 2016 Jul 5. pii: heartjnl-2016-309458. doi: 10.1136/heartjnl-2016-309458.
    PubMed     Text format     Abstract available


    June 2016
  23. ENDRIGHI R, Waters AJ, Gottlieb SS, Harris KM, et al
    Psychological stress and short-term hospitalisations or death in patients with heart failure.
    Heart. 2016 Jun 29. pii: heartjnl-2015-309154. doi: 10.1136/heartjnl-2015-309154
    PubMed     Text format     Abstract available


  24. SCALA O, Paolillo S, Formisano R, Pellegrino T, et al
    Sleep-disordered breathing, impaired cardiac adrenergic innervation and prognosis in heart failure.
    Heart. 2016 Jun 23. pii: heartjnl-2015-309215. doi: 10.1136/heartjnl-2015-309215
    PubMed     Text format     Abstract available


  25. OTTO CM, Rahimi K
    Heartbeat: The gut microbiota and heart failure.
    Heart. 2016;102:811-2.
    PubMed     Text format    


    May 2016
  26. HAUSER JA, Demyanets S, Rusai K, Goritschan C, et al
    Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
    Heart. 2016 May 24. pii: heartjnl-2016-309460. doi: 10.1136/heartjnl-2016-309460
    PubMed     Text format     Abstract available


  27. JHUND PS, McMurray JJ
    The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan.
    Heart. 2016 May 20. pii: heartjnl-2014-306775. doi: 10.1136/heartjnl-2014-306775
    PubMed     Text format     Abstract available


    March 2016
  28. TANG WW, Hazen SL
    Dietary metabolism, gut microbiota and acute heart failure.
    Heart. 2016 Mar 15. pii: heartjnl-2016-309268. doi: 10.1136/heartjnl-2016-309268
    PubMed     Text format    


  29. WONG FK, Ng AY, Lee PH, Lam PT, et al
    Effects of a transitional palliative care model on patients with end-stage heart failure: a randomised controlled trial.
    Heart. 2016 Mar 11. pii: heartjnl-2015-308638. doi: 10.1136/heartjnl-2015-308638
    PubMed     Text format     Abstract available


  30. BULLUCK H, Yellon DM, Hausenloy DJ
    Reducing myocardial infarct size: challenges and future opportunities.
    Heart. 2016;102:341-8.
    PubMed     Text format     Abstract available


    February 2016
  31. CLARK AM, Wiens K, Banner D, Kryworuchko J, et al
    A systematic review of the main mechanisms of heart failure disease management interventions.
    Heart. 2016 Feb 23. pii: heartjnl-2015-308551. doi: 10.1136/heartjnl-2015-308551
    PubMed     Text format     Abstract available


  32. PRIOR DL
    Back to the future: re-evaluation of the possible role for oxygen supplementation during exercise in chronic heart failure.
    Heart. 2016 Feb 18. pii: heartjnl-2015-309192. doi: 10.1136/heartjnl-2015-309192
    PubMed     Text format    


  33. KOSHY A, Pellicori P, Clark AL
    The effect of increasing inspired oxygen on exercise performance in patients with chronic heart failure.
    Heart. 2016 Feb 18. pii: heartjnl-2015-308932. doi: 10.1136/heartjnl-2015-308932
    PubMed     Text format     Abstract available


  34. LAM CS, Lund LH
    Microvascular endothelial dysfunction in heart failure with preserved ejection fraction.
    Heart. 2016;102:257-9.
    PubMed     Text format    


  35. OTTO CM
    Heartbeat: Microvascular dysfunction in heart failure with preserved ejection fraction.
    Heart. 2016;102:255-6.
    PubMed     Text format    


  36. SUZUKI T, Heaney LM, Bhandari SS, Jones DJ, et al
    Trimethylamine N-oxide and prognosis in acute heart failure.
    Heart. 2016 Feb 11. pii: heartjnl-2015-308826. doi: 10.1136/heartjnl-2015-308826
    PubMed     Text format     Abstract available


  37. REANT P, Mirabel M, Lloyd G, Peyrou J, et al
    Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy.
    Heart. 2016 Feb 8. pii: heartjnl-2015-308576. doi: 10.1136/heartjnl-2015-308576.
    PubMed     Text format     Abstract available


  38. CUBBON RM, Witte KK, Kearney LC, Gierula J, et al
    Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification.
    Heart. 2016 Feb 8. pii: heartjnl-2015-308939. doi: 10.1136/heartjnl-2015-308939.
    PubMed     Text format     Abstract available


    January 2016
  39. KWAN GF, Jean-Baptiste W, Cleophat P, Leandre F, et al
    Descriptive epidemiology and short-term outcomes of heart failure hospitalisation in rural Haiti.
    Heart. 2016;102:140-6.
    PubMed     Text format     Abstract available


  40. IACOBAZZI D, Suleiman MS, Ghorbel M, George SJ, et al
    Cellular and molecular basis of RV hypertrophy in congenital heart disease.
    Heart. 2016;102:12-7.
    PubMed     Text format     Abstract available


    December 2015
  41. MCKENZIE GA, Porter B, Kaprielian R
    An 89-year-old man presents with worsening heart failure.
    Heart. 2015 Dec 29. pii: heartjnl-2015-308725. doi: 10.1136/heartjnl-2015-308725
    PubMed     Text format    


  42. FRANSSEN C, Chen S, Hamdani N, Paulus WJ, et al
    From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress.
    Heart. 2015 Dec 16. pii: heartjnl-2015-307787. doi: 10.1136/heartjnl-2015-307787
    PubMed     Text format    


  43. CUBBON RM, Ruff N, Groves D, Eleuteri A, et al
    Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure.
    Heart. 2015 Dec 16. pii: heartjnl-2015-308428. doi: 10.1136/heartjnl-2015-308428
    PubMed     Text format     Abstract available


  44. MACIVER DH, Clark AL
    The key role of the RV in the pathogenesis of acute pulmonary oedema.
    Heart. 2015;101:1929-30.
    PubMed     Text format    


    November 2015
  45. TIETJENS J, Teerlink JR
    Serelaxin and acute heart failure.
    Heart. 2015 Nov 24. pii: heartjnl-2014-306786. doi: 10.1136/heartjnl-2014-306786
    PubMed     Text format     Abstract available


  46. LEE JF, Barrett-O'Keefe Z, Garten RS, Nelson AD, et al
    Evidence of microvascular dysfunction in heart failure with preserved ejection fraction.
    Heart. 2015 Nov 13. pii: heartjnl-2015-308403. doi: 10.1136/heartjnl-2015-308403
    PubMed     Text format     Abstract available


  47. MARTINEZ-GONZALEZ MA, Ruiz-Canela M
    Preventing heart failure: sweetened beverages and healthy lifestyles.
    Heart. 2015 Nov 2. pii: heartjnl-2015-308426. doi: 10.1136/heartjnl-2015-308426.
    PubMed     Text format    


  48. RAHMAN I, Wolk A, Larsson SC
    The relationship between sweetened beverage consumption and risk of heart failure in men.
    Heart. 2015 Nov 2. pii: heartjnl-2015-307542. doi: 10.1136/heartjnl-2015-307542.
    PubMed     Text format     Abstract available


  49. OTTO CM
    Heartbeat: Highlights from this issue.
    Heart. 2015;101:1769-70.
    PubMed     Text format    


  50. KRAMER DB, Hatfield LA, Normand SL
    Comparative effectiveness of cardiac implantable electrical devices.
    Heart. 2015;101:1773-5.
    PubMed     Text format    


  51. KANG DH
    Timing of surgery in infective endocarditis.
    Heart. 2015;101:1786-91.
    PubMed     Text format     Abstract available


  52. WOODS B, Hawkins N, Mealing S, Sutton A, et al
    Individual patient data network meta-analysis of mortality effects of implantable cardiac devices.
    Heart. 2015;101:1800-6.
    PubMed     Text format     Abstract available


    October 2015
  53. GUNDERSEN GH, Norekval TM, Haug HH, Skjetne K, et al
    Adding point of care ultrasound to assess volume status in heart failure patients in a nurse-led outpatient clinic. A randomised study.
    Heart. 2015 Oct 5. pii: heartjnl-2015-307798. doi: 10.1136/heartjnl-2015-307798.
    PubMed     Text format     Abstract available


    September 2015
  54. REINSTADLER SJ, Baum A, Rommel KP, Eitel C, et al
    ST-segment depression resolution predicts infarct size and reperfusion injury in ST-elevation myocardial infarction.
    Heart. 2015 Sep 18. pii: heartjnl-2015-307876. doi: 10.1136/heartjnl-2015-307876
    PubMed     Text format     Abstract available


  55. BOSSEAU C, Galli E, Donal E
    Prognostic value of BNP in heart failure with preserved or reduced EJ.
    Heart. 2015 Sep 11. pii: heartjnl-2015-308515. doi: 10.1136/heartjnl-2015-308515
    PubMed     Text format    


  56. ERDEI T, Aakhus S, Marino P, Paulus WJ, et al
    Pathophysiological rationale and diagnostic targets for diastolic stress testing.
    Heart. 2015;101:1355-60.
    PubMed     Text format     Abstract available


  57. CLELAND JG, Freemantle N
    QRS morphology as a predictor of the response to cardiac resynchronisation therapy: fact or fashion?
    Heart. 2015;101:1441-3.
    PubMed     Text format    


    August 2015
  58. KANG SH, Park JJ, Choi DJ, Yoon CH, et al
    Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF.
    Heart. 2015 Aug 28. pii: heartjnl-2015-307782. doi: 10.1136/heartjnl-2015-307782
    PubMed     Text format     Abstract available


  59. DEVORE AD, Hernandez AF
    Measuring heart failure quality: does perfection matter?
    Heart. 2015 Aug 3. pii: heartjnl-2015-308185. doi: 10.1136/heartjnl-2015-308185.
    PubMed     Text format    


  60. FUCHS FD, Martinez D
    Obstructive sleep apnoea should be deemed a cardiovascular disease.
    Heart. 2015;101:1261-2.
    PubMed     Text format    


  61. COSTA LE, Uchoa CH, Harmon RR, Bortolotto LA, et al
    Potential underdiagnosis of obstructive sleep apnoea in the cardiology outpatient setting.
    Heart. 2015;101:1288-92.
    PubMed     Text format     Abstract available


    June 2015
  62. VIAU DM, Sala-Mercado JA, Spranger MD, O'Leary DS, et al
    The pathophysiology of hypertensive acute heart failure.
    Heart. 2015 Jun 29. pii: heartjnl-2015-307461. doi: 10.1136/heartjnl-2015-307461
    PubMed     Text format     Abstract available


  63. BOTTLE A, Goudie R, Cowie MR, Bell D, et al
    Relation between process measures and diagnosis-specific readmission rates in patients with heart failure.
    Heart. 2015 Jun 11. pii: heartjnl-2014-307328. doi: 10.1136/heartjnl-2014-307328
    PubMed     Text format     Abstract available


  64. BRIASOULIS A, Mallikethi-Reddy S, Palla M, Alesh I, et al
    Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis.
    Heart. 2015 Jun 9. pii: heartjnl-2015-307682. doi: 10.1136/heartjnl-2015-307682.
    PubMed     Text format     Abstract available


  65. JOHANSSON I, Dahlstrom U, Edner M, Nasman P, et al
    Risk factors, treatment and prognosis in men and women with heart failure with and without diabetes.
    Heart. 2015 Jun 1. pii: heartjnl-2014-307131. doi: 10.1136/heartjnl-2014-307131.
    PubMed     Text format     Abstract available


  66. PATEL V, O'Mahony C, Hughes D, Rahman MS, et al
    Clinical and genetic predictors of major cardiac events in patients with Anderson-Fabry Disease.
    Heart. 2015;101:961-6.
    PubMed     Text format     Abstract available


    May 2015
  67. PELLICORI P, Kallvikbacka-Bennett A, Dierckx R, Zhang J, et al
    Prognostic significance of ultrasound-assessed jugular vein distensibility in heart failure.
    Heart. 2015 May 25. pii: heartjnl-2015-307558. doi: 10.1136/heartjnl-2015-307558
    PubMed     Text format     Abstract available


  68. DELGADO V, Bax JJ
    Diastolic dysfunction and atrial fibrillation.
    Heart. 2015 May 18. pii: heartjnl-2015-307885. doi: 10.1136/heartjnl-2015-307885
    PubMed     Text format    


  69. TATEISHI E, Noguchi T, Goto Y, Morita Y, et al
    Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy.
    Heart. 2015;101:774-80.
    PubMed     Text format     Abstract available


  70. TIWARI S, Schirmer H, Jacobsen BK, Hopstock LA, et al
    Association between diastolic dysfunction and future atrial fibrillation in the Tromso Study from 1994 to 2010.
    Heart. 2015 May 13. pii: heartjnl-2015-307438. doi: 10.1136/heartjnl-2015-307438
    PubMed     Text format     Abstract available


  71. KIRKPATRICK JN, Wieselthaler G, Strueber M, St John Sutton MG, et al
    Ventricular assist devices for treatment of acute heart failure and chronic heart failure.
    Heart. 2015 May 6. pii: heartjnl-2014-306789. doi: 10.1136/heartjnl-2014-306789.
    PubMed     Text format     Abstract available


    April 2015
  72. LALANI GG, Birgersdotter-Green U
    Cardiac resynchronisation therapy in patients with chronic heart failure.
    Heart. 2015 Apr 16. pii: heartjnl-2014-306835. doi: 10.1136/heartjnl-2014-306835
    PubMed     Text format     Abstract available


    March 2015
  73. MOYA-MUR JL, Hinojar R, Zamorano JL
    Heart failure in a patient with a pacemaker.
    Heart. 2015;101:484.
    PubMed     Text format    


  74. HOLMQVIST F, Kim S, Steinberg BA, Reiffel JA, et al
    Heart rate is associated with progression of atrial fibrillation, independent of rhythm.
    Heart. 2015 Mar 2. pii: heartjnl-2014-307043. doi: 10.1136/heartjnl-2014-307043.
    PubMed     Text format     Abstract available


    February 2015
  75. CUNNINGTON C, Kwok CS, Satchithananda DK, Patwala A, et al
    Cardiac resynchronisation therapy is not associated with a reduction in mortality or heart failure hospitalisation in patients with non-left bundle branch block QRS morphology: meta-analysis of randomised controlled trials.
    Heart. 2015 Feb 12. pii: heartjnl-2014-306811. doi: 10.1136/heartjnl-2014-306811
    PubMed     Text format     Abstract available


    January 2015
  76. CALLENDER T, Rahimi K
    Heart failure and iron deficiency anaemia: a complex dance.
    Heart. 2015 Jan 30. pii: heartjnl-2014-307227. doi: 10.1136/heartjnl-2014-307227
    PubMed     Text format    


    December 2014
  77. MAKUBI A, Hage C, Lwakatare J, Mmbando B, et al
    Prevalence and prognostic implications of anaemia and iron deficiency in Tanzanian patients with heart failure.
    Heart. 2014 Dec 24. pii: heartjnl-2014-306890. doi: 10.1136/heartjnl-2014-306890
    PubMed     Text format     Abstract available


    November 2014
  78. HO JE, Magnani JW
    The MESA heart failure risk score: can't we do more?
    Heart. 2014 Nov 11. pii: heartjnl-2014-306459. doi: 10.1136/heartjnl-2014-306459
    PubMed     Text format    


  79. CHAHAL H, Bluemke DA, Wu CO, McClelland R, et al
    Heart failure risk prediction in the Multi-Ethnic Study of Atherosclerosis.
    Heart. 2014 Nov 7. pii: heartjnl-2014-305697. doi: 10.1136/heartjnl-2014-305697.
    PubMed     Text format     Abstract available


  80. APELLAND T, Gude E, Strom EH, Gullestad L, et al
    Familial globotriaosylceramide-associated cardiomyopathy mimicking Fabry disease.
    Heart. 2014;100:1793-8.
    PubMed     Text format     Abstract available


  81. LIU K
    Does the heart have a mind of its own? Prevent adverse outcome from Takotsubo cardiomyopathy.
    Heart. 2014;100:1816.
    PubMed     Text format    


  82. PANT S, Patel NJ, Deshmukh A
    Takotsubo cardiomyopathy.
    Heart. 2014;100:1816-7.
    PubMed     Text format    


  83. GHADRI JR, Ruschitzka F, Luscher TF, Templin C, et al
    Takotsubo cardiomyopathy: still much more to learn.
    Heart. 2014;100:1804-12.
    PubMed     Text format    


    October 2014
  84. MAGNE J, Donal E, Mahjoub H, Miltner B, et al
    Impact of exercise pulmonary hypertension on postoperative outcome in primary mitral regurgitation.
    Heart. 2014 Oct 17. pii: heartjnl-2014-306296. doi: 10.1136/heartjnl-2014-306296
    PubMed     Text format     Abstract available


    September 2014
  85. JANDER N, Hochholzer W, Kaufmann BA, Bahlmann E, et al
    Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF.
    Heart. 2014 Sep 12. pii: heartjnl-2014-305763. doi: 10.1136/heartjnl-2014-305763
    PubMed     Text format     Abstract available


    July 2014
  86. COWIE MR
    Ivabradine and atrial fibrillation: what should we tell our patients?
    Heart. 2014 Jul 1. pii: heartjnl-2014-306287. doi: 10.1136/heartjnl-2014-306287.
    PubMed     Text format    


    June 2014
  87. MARTIN RI, Pogoryelova O, Santibanez Koref M, Bourke JP, et al
    Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.
    Heart. 2014 Jun 20. pii: heartjnl-2014-305482. doi: 10.1136/heartjnl-2014-305482
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: